↓ Skip to main content

Comparative Cost Analysis Of Intravenous And Subcutaneous Administration Of Rituximab In Lymphoma Patients

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, November 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#18 of 374)
  • High Attention Score compared to outputs of the same age (92nd percentile)

Mentioned by

blogs
1 blog
twitter
29 tweeters
facebook
1 Facebook page

Readers on

mendeley
1 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
<p>Comparative Cost Analysis Of Intravenous And Subcutaneous Administration Of Rituximab In Lymphoma Patients</p>
Published in
ClinicoEconomics and Outcomes Research: CEOR, November 2019
DOI 10.2147/ceor.s212257
Pubmed ID
Authors

Olga Delgado Sánchez, Antonio Gutierrez, Fernando do Pazo, Jordi Gines, Clara Martorell, Bàrbara Boyeras Vallespir, Leyre Bento, Marta Garcia-Recio, Antonia Sampol

Twitter Demographics

The data shown below were collected from the profiles of 29 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 1 Mendeley reader of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 1 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 1 100%
Readers by discipline Count As %
Computer Science 1 100%

Attention Score in Context

This research output has an Altmetric Attention Score of 28. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 February 2020.
All research outputs
#650,891
of 14,376,314 outputs
Outputs from ClinicoEconomics and Outcomes Research: CEOR
#18
of 374 outputs
Outputs of similar age
#25,680
of 325,701 outputs
Outputs of similar age from ClinicoEconomics and Outcomes Research: CEOR
#1
of 1 outputs
Altmetric has tracked 14,376,314 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 374 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.8. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 325,701 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them